analyst
EL
NASDAQ · ELTX
Elicio Therapeutics, Inc.
Healthcare · Biotechnology
$1.99
Down-$0.20 (-9.80%)
Updated Sep 16, 2026, 6:19 PM
SID Score
2.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 144.37M
- P/E ratio
- -3.04
- Dividend yield
- 0.00%
- 52-week range
- $1.92 – $16.00
- Volume
- 319.02K
- Avg. volume
- 97.45K
Price performance
ELTX price history
1M range · 20 trading sessions · Daily adjusted prices
ELTX closed at $1.99 after 20 trading sessions, down 36.01% for the selected period.
- Last close
- $1.99
- Period change
- -36.01%
- Period low
- $1.99
- Period high
- $3.13
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $2.01 | $2.02 | $1.915 | $1.99 | 319.02K |
| Sep 14, 2026 | $2.06 | $2.0899 | $1.95 | $2.00 | 391.83K |
| Sep 11, 2026 | $2.14 | $2.20 | $2.02 | $2.05 | 445.8K |
| Sep 10, 2026 | $2.17 | $2.20 | $2.07 | $2.11 | 343.24K |
| Sep 9, 2026 | $2.37 | $2.375 | $2.17 | $2.18 | 459.08K |
| Sep 8, 2026 | $2.42 | $2.46 | $2.34 | $2.35 | 324.72K |
| Sep 4, 2026 | $2.50 | $2.50 | $2.36 | $2.41 | 487.92K |
| Sep 3, 2026 | $2.55 | $2.56 | $2.465 | $2.50 | 272.71K |
| Sep 2, 2026 | $2.57 | $2.61 | $2.48 | $2.55 | 397.65K |
| Sep 1, 2026 | $2.70 | $2.71 | $2.55 | $2.56 | 334.84K |
| Aug 31, 2026 | $2.84 | $2.8699 | $2.70 | $2.70 | 412.19K |
| Aug 28, 2026 | $3.00 | $3.00 | $2.84 | $2.84 | 421.56K |
| Aug 27, 2026 | $3.00 | $3.05 | $2.97 | $3.00 | 131.24K |
| Aug 26, 2026 | $3.00 | $3.07 | $2.96 | $2.98 | 182.66K |
| Aug 25, 2026 | $3.00 | $3.095 | $2.9804 | $3.01 | 223.61K |
| Aug 24, 2026 | $3.06 | $3.06 | $2.94 | $2.98 | 311.99K |
| Aug 21, 2026 | $3.11 | $3.11 | $3.03 | $3.04 | 279.37K |
| Aug 20, 2026 | $3.11 | $3.135 | $3.02 | $3.075 | 207.77K |
| Aug 19, 2026 | $3.34 | $3.36 | $3.04 | $3.13 | 502.61K |
| Aug 18, 2026 | $3.03 | $3.12 | $2.98 | $3.11 | 389.1K |
Latest ELTX news
The latest Smart Investors Daily articles mentioning ELTX.
Stock researchCompany · Financials
Loading stock research…

